10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients
JACC: Heart Failure · 2026-08 · 14 (8) · 103115
DOI: 10.1016/j.jchf.2026.103115 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Heart Failure, 2026-08. Verfasst von Ameesh Isath und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mass General Brigham Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Kidney Transplantation, Reoperation, Heart Failure. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Renal dysfunction is common in heart retransplant (re-HT) candidates and adversely influences outcomes. Although simultaneous heart-kidney transplantation (SHKT) is established in primary transplantation for severe renal dysfunction, its long-term benefit in the re-HT setting remains incompletely defined. OBJECTIVES This study sought to evaluate 10-year survival and renal trajectories after SHKT compared with isolated re-HT. METHODS Adult patients undergoing re-HT (2000-2024) were identified from the UNOS (United Network for Organ Sharing) registry and categorized as isolated re-HT or simultaneous heart-kidney retransplantation (re-SHKT). The primary outcome was 10-year survival. Secondary outcomes evaluated renal outcomes, rejection, and cardiac allograft vasculopathy. Multivariable Cox regression and Fine-Gray competing risk models were used to adjust for recipient, donor, and era-related covariates. RESULTS Among 1,378 re-HT recipients, 304 (22%) underwent re-SHKT. Despite worse baseline renal function, re-SHKT was associated with improved 10-year survival (71.2% vs 59.1%, respectively; adjusted HR: 0.51; 95% CI: 0.38-0.70; P < 0.001). Survival benefit was observed in recipients with a pretransplant estimated glomerular filtration rate (eGFR)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mass General Brigham Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Cardiac Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Mass General Brigham Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiothoracic and Vascular Surgery, German Heart Center of Charité, Berlin, Germany.
- Mass General Brigham Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts, USA; Cardiac Surgery Clinic, University Clinical Center of Serbia, Belgrade, Serbia.
- Center for Surgery and Public Health, Department of Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Mass General Brigham Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: mmehra@bwh.harvard.edu.
Zitieren
APA
Isath, A., Tadokoro, N., Schoenrath, F., Vukićević, M., Faria, V., Dey, T., Godding, M., Givertz, M. M., Itoh, A., & Mehra, M. R. (2026). 10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients. JACC: Heart Failure, 14(8), 103115. https://doi.org/10.1016/j.jchf.2026.103115
Vancouver
Isath A, Tadokoro N, Schoenrath F, Vukićević M, Faria V, Dey T, et al. 10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients. JACC: Heart Failure. 2026;14(8):103115. doi:10.1016/j.jchf.2026.103115
BibTeX
@article{Isath2026,
author = {Isath, Ameesh and Tadokoro, Naoki and Schoenrath, Felix and Vukićević, Milica and Faria, Vanessa and Dey, Tanujit and Godding, Mark and Givertz, Michael M and Itoh, Akinobu and Mehra, Mandeep R},
title = {10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients},
journal = {JACC: Heart Failure},
year = {2026},
volume = {14},
number = {8},
pages = {103115},
doi = {10.1016/j.jchf.2026.103115}
}
EUVIMED